Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	AZD3355 60 mg	134
Overall Study	STARTED	AZD3355 120 mg	125
Overall Study	STARTED	AZD3355 180 mg	136
Overall Study	STARTED	AZD3355 240 mg	126
Overall Study	STARTED	Placebo	140
Overall Study	COMPLETED	AZD3355 60 mg	121
Overall Study	COMPLETED	AZD3355 120 mg	109
Overall Study	COMPLETED	AZD3355 180 mg	114
Overall Study	COMPLETED	AZD3355 240 mg	114
Overall Study	COMPLETED	Placebo	122
Overall Study	NOT COMPLETED	AZD3355 60 mg	13
Overall Study	NOT COMPLETED	AZD3355 120 mg	16
Overall Study	NOT COMPLETED	AZD3355 180 mg	22
Overall Study	NOT COMPLETED	AZD3355 240 mg	12
Overall Study	NOT COMPLETED	Placebo	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01005251/flow